Clinical Trials
4 trialsNCT06569368 2026-04-16
Trial Utilizing Metronidazole to Optimize the Microbiome of Rectal Adenocarcinoma Undergoing Neoadjuvant Therapy
M.D. Anderson Cancer Center
Phase 2 Recruiting
NCT06793137 2025-01-29
Intestinal Microbiome Modulation With Antibiotics in the Neoadjuvant Treatment of Locally Advanced Rectal Cancer
AC Camargo Cancer Center
Phase 2 Recruiting
NCT01345175 2024-05-14
Rifaximin and Placebo in the Treatment of Bowel Dysfunction After Anterior Resection for Rectal Cancer
Memorial Sloan Kettering Cancer Center
Phase 3 Completed
NCT02682485 2023-04-26
SES-DTA
University of Chicago
Phase 2 Withdrawn